Merck & Company, Inc. (new) (MRK) earnings
MRK earnings moved a median of -0.05% by the close. Quarterly and annual MRK reports and results, each read against the price at its own news timestamp. Back to the MRK overview →
44 measured MRK earnings events.
Where these MRK earnings landedvs 42 measured MRK earnings reactions
| Middle 50% of MRK earnings reactions | -0.60% to +0.62% |
|---|---|
| Median reaction (to close) | -0.05% |
| Measured reactions | 42 |
Point-in-time · zero look-ahead
Half of the 42 MRK earnings events with a measured close landed between -0.60% and +0.62%; 43% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Merck to Hold Third-Quarter 2026 Sales and Earnings Conference Call Oct. 29 | Press release | -0.14% | -0.62% | |
| Form 10-Q Merck & Co., Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.77% | — | |
| Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline | Press release | -2.21% | -0.94% | |
| Merck Announces Fourth-Quarter 2026 Dividend | Press release | +0.35% | -0.10% | |
| Merck to Hold Second-Quarter 2026 Sales and Earnings Conference Call Aug. 4 | Press release | -0.66% | -2.06% | |
| Merck Announces Third-Quarter 2026 Dividend | Press release | -0.00% | -0.79% | |
| Form 10-Q Merck & Co., Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.12% | -0.25% | |
| Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical Milestones | Press release | -1.90% | -2.25% | |
| Merck to Hold First-Quarter 2026 Sales and Earnings Conference Call April 30 | Press release | +0.80% | -0.03% | |
| Form 10-K Merck & Co., Inc. For: Dec 31 | SEC filing · Form 10-K | +0.41% | -1.34% | |
| Merck Announces Second-Quarter 2026 Dividend | Press release | +0.02% | +0.20% | |
| Merck to Hold Fourth-Quarter and Full-Year 2025 Sales and Earnings Conference Call Feb. 3 | Press release | +0.36% | -0.96% | |
| Merck Announces First-Quarter 2026 Dividend | Press release | -0.30% | +0.21% | |
| Form 10-Q Merck & Co., Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.09% | +1.27% | |
| Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter 2025 Financial Results | Press release | +1.01% | +2.73% | |
| Merck to Hold Third-Quarter 2025 Sales and Earnings Conference Call Oct. 30 | Press release | +0.42% | +5.23% | |
| Form 10-Q Merck & Co., Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.58% | -1.21% | |
| Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2025 Financial Results | Press release | -2.74% | — | |
| Merck Announces Fourth-Quarter 2025 Dividend | Press release | +0.06% | +0.42% | |
| Merck to Hold Second-Quarter 2025 Sales and Earnings Conference Call July 29 | Press release | -0.26% | +3.49% | |
| Merck Announces Third-Quarter 2025 Dividend | Press release | -0.22% | -0.15% | |
| Form 10-Q Merck & Co., Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.13% | -0.54% | |
| Merck Announces First-Quarter 2025 Financial Results | Press release | -1.82% | +1.50% | |
| Merck to Hold First-Quarter 2025 Sales and Earnings Conference Call April 24 | Press release | -0.47% | -2.68% | |
| Merck Announces Second-Quarter 2025 Dividend and $10 Billion Share Repurchase Authorization | Press release | +1.03% | +0.25% | |
| Merck to Hold Fourth-Quarter and Full-Year 2024 Sales and Earnings Conference Call Feb. 4 | Press release | -0.01% | +0.52% | |
| Merck Announces First-Quarter 2025 Dividend | Press release | +0.22% | +0.64% | |
| Form 10-Q Merck & Co., Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.40% | -0.26% | |
| Merck Announces Third-Quarter 2024 Financial Results | Press release | -1.70% | +1.17% | |
| Merck to Hold Third-Quarter 2024 Sales and Earnings Conference Call Oct. 31 | Press release | -0.37% | +0.65% | |
| Form 10-Q Merck & Co., Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.20% | -1.04% | |
| Merck Announces Second-Quarter 2024 Financial Results | Press release | -1.98% | -6.47% | |
| Merck Announces Fourth-Quarter 2024 Dividend | Press release | -0.06% | -0.34% | |
| Merck to Hold Second-Quarter 2024 Sales and Earnings Conference Call July 30 | Press release | +1.59% | +2.00% | |
| Merck Announces Third-Quarter 2024 Dividend | Press release | -0.04% | -0.04% | |
| Form 10-Q Merck & Co., Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.36% | +0.45% | |
| Merck Announces First-Quarter 2024 Financial Results | Press release | +1.45% | +0.55% | |
| Form 10-K/A Merck & Co., Inc. For: Dec 31 | SEC filing · Form 10-K | +0.09% | -0.42% | |
| Merck to Hold First-Quarter 2024 Sales and Earnings Conference Call April 25 | Press release | -0.12% | -0.52% | |
| Form 10-K Merck & Co., Inc. For: Dec 31 | SEC filing · Form 10-K | -0.08% | +0.71% | |
| Merck Announces Second-Quarter 2024 Dividend | Press release | -0.10% | -0.07% | |
| Merck to Hold Fourth-Quarter and Full-Year 2023 Sales and Earnings Conference Call Feb. 1 | Press release | +0.09% | +0.72% | |
| Merck Announces First-Quarter 2024 Dividend | Press release | +0.05% | -0.33% | |
| Form 10-Q Merck & Co., Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.52% | -0.02% |
Keep exploring
More MRK: analyst actions → · SEC filings → · MRK overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| MOMENTA PHARMACEUTICALS (MNTA) | 1,355 | 0.00% | 46% |
| Clovis Oncology, Inc. (CLVS) | 1,349 | -0.20% | 47% |
| Humana Inc. (HUM) | 1,306 | +0.02% | 51% |
| WELLCARE HEALTH PLANS (WCG) | 1,292 | 0.00% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.